Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The Aliya Headlines, and What They Actually Signal
The reporting on Aliya Health Group over the last several months has covered layoffs, facility closures across multiple states, and a leadership change at the top. Read the trade press and it looks like a single company’s hard year. Look at it through the lens of operator advisory work and it looks like a pattern we have watched repeat across PE-backed multi-site behavioral health platforms since roughly 2022.
The pattern goes like this. A platform expands quickly between 2018 and 2021, often through tuck-in acquisitions of single-site operators. Reimbursement assumptions baked into the underwriting were built on a payer mix and a length-of-stay environment that no longer exists. Then UR pressure tightens, commercial single-case agreements get harder to land, and a few sites that always ran thin on census tip into negative contribution margin. New leadership comes in. The portfolio gets re-cut.
Aliya is not unique. It is just visible.
What Actually Triggers the Turnaround Moment
When we get the call from a board or a new CEO, the trigger is almost never one thing. It is usually three things stacked. Unit economics at two or three sites have been underwater for four to six quarters. Payer mix has shifted ten to fifteen points away from commercial toward Medicaid or self-pay without a corresponding cost structure adjustment. And the platform expanded into a state or a level of care where the licensing burden, staffing ratios, or local market saturation made the original pro forma fiction.
Add a covenant conversation with the lender and you get the 90-day review. The new CEO walks in, asks for site-level P&Ls, asks for census trends by referral source, asks which licenses are in good standing and which have open plans of correction. By day 30 they usually know which sites are keepers, which are fixable, and which are going to close. By day 60 they are pressure-testing those instincts against real feasibility data. By day 90 there is a board deck.
The operators who do this well do not wait for the lender to force the conversation. They run the analysis annually, on their own footprint, while they still have options.
Feasibility Studies and Pro Formas as Decision Tools, Not Sales Documents
A feasibility study built to attract capital and a feasibility study built to decide whether to close a facility are different documents. The first one tends to be optimistic about ramp, generous about payer mix, and quiet about competitive saturation. The second one has to be honest or it is useless.
When AHS supports a portfolio review, the pro forma work looks at site-level census against realistic referral capacity in the catchment, current and projected reimbursement by payer with actual contracted rates, staffing models that match the ASAM Criteria, 4th Edition acuity for the level of care being delivered, and the fixed cost floor that does not move whether the site runs at 40 percent or 80 percent occupancy. We also look at the licensure picture honestly. A facility with two open corrective action plans and a pending complaint survey is not the same risk profile as a clean site, and that has to show up in the numbers.
The output is not a recommendation to close or keep. The output is a defensible basis for the board to make that call with eyes open.
The Licensure Mechanics of Closing or Consolidating
This is where operators get hurt. Closing a residential facility is not just turning off the lights. Depending on the state, you have notification requirements to the licensing agency, patient transition plans that have to be documented and in many cases pre-approved, accreditation withdrawal or suspension processes with Joint Commission or CARF, DEA registration surrender if there is an OTP or controlled substance component, and Medicaid and Medicare deactivation steps that have to be sequenced correctly to avoid recoupment exposure on the way out.
Consolidating two sites in the same state into one license is its own project. Some states treat it as a new license application. Some allow a modification. The difference can be six months on the timeline. Closing across states multiplies every one of these workstreams. We have seen operators announce a closure publicly before the state agency was notified, which is a fast way to turn a business decision into an enforcement matter.
The right sequence is: model the decision, validate the licensure path with each state agency in writing, build the patient transition plan, then communicate. Not the other way around.
Stress-Testing the Footprint Before Crisis
The operators who avoid the Aliya headline cycle are not smarter. They just look earlier. An annual portfolio stress test, run independently of the budget process, catches the underwater site at quarter four of year one instead of quarter four of year three. That is the difference between a managed wind-down and a layoff announcement.
Leah Kendall and I will be at the West Coast Symposium for Addictive Disorders in late May, and this is one of the conversations we expect to have repeatedly with operators and investors in the room. The platforms that came out of the 2018 to 2021 expansion are at a decision point. Some will contract gracefully. Some will contract under duress. The ones who plan for it have more options than the ones who don’t.
If you are a CEO or board member looking at a footprint that does not feel right, the work to fix it is finite and knowable. The longer you wait, the fewer levers you have. One step at a time, with the right people around the table, and an honest set of numbers.
References
- Behavioral Health Business: coverage of Aliya Health Group operations and industry consolidation
- American Society of Addiction Medicine: The ASAM Criteria, 4th Edition
- SAMHSA: Substance Use Treatment Locator and Provider Resources
- The Joint Commission: Accreditation and Certification Processes
- CARF International: Accreditation Standards and Withdrawal Procedures
- CMS: Provider Enrollment, Deactivation, and Revalidation